Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP618746.RAc2JUax_vbUirmch2hL7N9sv50PT4WeA3RWE0lXZ-bIQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP618746.RAc2JUax_vbUirmch2hL7N9sv50PT4WeA3RWE0lXZ-bIQ130_assertion type Assertion NP618746.RAc2JUax_vbUirmch2hL7N9sv50PT4WeA3RWE0lXZ-bIQ130_head.
- NP618746.RAc2JUax_vbUirmch2hL7N9sv50PT4WeA3RWE0lXZ-bIQ130_assertion description "[EGFR kinase inhibitors constitute an important class of lung cancer treatments.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618746.RAc2JUax_vbUirmch2hL7N9sv50PT4WeA3RWE0lXZ-bIQ130_provenance.
- NP618746.RAc2JUax_vbUirmch2hL7N9sv50PT4WeA3RWE0lXZ-bIQ130_assertion evidence source_evidence_literature NP618746.RAc2JUax_vbUirmch2hL7N9sv50PT4WeA3RWE0lXZ-bIQ130_provenance.
- NP618746.RAc2JUax_vbUirmch2hL7N9sv50PT4WeA3RWE0lXZ-bIQ130_assertion SIO_000772 17613432 NP618746.RAc2JUax_vbUirmch2hL7N9sv50PT4WeA3RWE0lXZ-bIQ130_provenance.
- NP618746.RAc2JUax_vbUirmch2hL7N9sv50PT4WeA3RWE0lXZ-bIQ130_assertion wasDerivedFrom befree-2016 NP618746.RAc2JUax_vbUirmch2hL7N9sv50PT4WeA3RWE0lXZ-bIQ130_provenance.
- NP618746.RAc2JUax_vbUirmch2hL7N9sv50PT4WeA3RWE0lXZ-bIQ130_assertion wasGeneratedBy ECO_0000203 NP618746.RAc2JUax_vbUirmch2hL7N9sv50PT4WeA3RWE0lXZ-bIQ130_provenance.